Natural History and Long-term Outcome of Chronic Hepatitis B Virus Infection

doi:10.3969/j.issn.1006-7795.2010.05.013

Abstract

Abstract: Chronic hepatitis B virus(HBV) infection is a state of interactions among HBV, the hepatocytes and the immune system of the patient. The natural course of chronic HBV infection is now thought as comprising 3 phases: immune tolerance, immune clearance

$HBeAg-positive chronic hepatitis$ , carrier state, and now HBeAg-negative chronic hepatitis B is also considered as a particular phase. Understanding the natural history of chronic HBV infection is crucial in the management of HBV infected patients and underscores the need for long-term monitoring. Accumulating evidence indicates that antiviral therapy can prevent progression of HBV-related liver disease, particularly among patients with sustained response. Pegylated interferon(IFN) and newer nucleos(t)ide analogues may have even better long-term outcomes because of better therapeutic efficacy and/or a low risk of drug resistances. The treatment outcomes are still far from satisfactory. The development of safe and affordable anti-HBV agents or strategies is needed to further improve outcomes.

Key words: hepatitis B virus, liver cirrhosis, hepatocellular carcinoma, antiviral, natural history

CLC Number:

R 575

WANG Hui, JIA Ji-dong. Natural History and Long-term Outcome of Chronic Hepatitis B Virus Infection[J]. Journal of Capital Medical University, 2010, 31(5): 582-585.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2010.05.013

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2010/V31/I5/582

[1]	Yin Xue, Yu Minghang, Wang Xi, Chen Jinglong. Progresses on the mutation of SWI/SNF complex and its impact on immune checkpoint inhibitor therapy response in hepatocellular carcinoma [J]. Journal of Capital Medical University, 2023, 44(5): 768-774.
[2]	Wan Yan, Liu Fang, Guo Shan, Wu Jian. Transcriptome sequencing and survival analysis of noncirrhotic hepatitis B viral（HBV）-related hepatocellular carcinoma [J]. Journal of Capital Medical University, 2023, 44(5): 811-820.
[3]	Tan Yubo, Suboyinuer Tuerhong, Huang Jing, Zhang Tingting, Liu Junjie, Shaya Mahati. The mechanism of miR-150 targeted regulation of IGF2BP2 on the malignant phenotype of liver cancer [J]. Journal of Capital Medical University, 2023, 44(5): 762-767.
[4]	Feng Ying, Shi Ke, Wang Xianbo. Establishment and validation of 2-year predictive scoring model for patients with liver cirrhosis complicated with superior mesenteric venous thrombosis [J]. Journal of Capital Medical University, 2023, 44(1): 107-114.
[5]	An Songlin, Ma Ling, Zhao Yue, Li Yan. Effects of major facilitator superfamily domain containing 2A on the cell proliferation, apoptosis and invasion of human hepatocellular carcinoma [J]. Journal of Capital Medical University, 2021, 42(6): 1000-1006.
[6]	Li Muchan, Xu Chunjun, Wang Yutao, Wang Cong. Clinical study on improving the quality of life in patients with early and middle stages hepatocellular carcinoma [J]. Journal of Capital Medical University, 2019, 40(3): 352-357.
[7]	Shen Yanjun, Chen Jinglong, Che Juanjuan, Wang Jing, Cao Bangwei. Occurrence and prognosis value of Snail and Claudin-3 expression in hepatocelluar carcinoma [J]. Journal of Capital Medical University, 2018, 39(3): 393-397.
[8]	Sun Haiqing, Lou Jinli. Infectious diseases survey of estimated glomerular filtration rate in patients with liver cirrhosis and liver cancer of Beijing Youan Hospital, Capital Medical University from 2015 to 2016 [J]. Journal of Capital Medical University, 2017, 38(4): 541-545.
[9]	Bai Jing, Zhang Lijun, Zhan Yutao, Guo Duo, Liu Xiangyi. Chemiluminescence immunoassay for Golgi protein 73 in human serum and its clinical application [J]. Journal of Capital Medical University, 2017, 38(4): 566-571.
[10]	Wang Zheng, Ding Huiguo, Chen Yuhan, Li Lei, Fan Chunlei, Dong Peiling. Changes of the aetiologies of cirrhosis and its complications in north China [J]. Journal of Capital Medical University, 2017, 38(4): 604-608.
[11]	Wang Tiezheng, Wu Jushan, Meng Fankun, Zang Yunjin, Lin Dongdong, Li Jian, Li Ning. Value of instantaneous elastic measurement on non invasive diagnosis of early hepatitis B -related liver cirrhosis [J]. Journal of Capital Medical University, 2017, 38(2): 299-303.
[12]	Wang Fang, Chen Mingkai, Xiao Yong, Liu Shiqian, Zeng Xi, Wu Nannan, Zhang Jin, Li Xin. Analysis of the effect of different sequential therapy on the treatment of esophageal varices bleeding for secondary prophylaxis [J]. Journal of Capital Medical University, 2016, 37(5): 602-606.
[13]	Zhang Qi, Li Hongjun, Li Yunfang, Zhang Yanyan, Yuan Xingxing, Chang Jing. MR enhancement features of multistep hepatocarcinogenesis in HBV-related cirrhotic livers: correlation with GPC-3 and CD34 [J]. Journal of Capital Medical University, 2016, 37(5): 672-679.
[14]	Fang Fang, Chen Kelin, Chen Yan, Huang Zeyu, Lyu Hong, Liu Shujing, Zhou Jin, Zhang Guojun, Kang Xixiong. Evaluation of anti-interference capability of HBV DNA quantitative reagents according to CNAS CL-36 criterion [J]. Journal of Capital Medical University, 2016, 37(4): 495-499.
[15]	Dang Yan, Zhang Lili, Lou Jinli, Chen Ming. Values of ascites and plasma procalcitonin in diagnosis of liver cirrhosis with spontaneous bacterial peritonitis [J]. Journal of Capital Medical University, 2015, 36(4): 597-600.

Natural History and Long-term Outcome of Chronic Hepatitis B Virus Infection

PDF

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments